Prophylactic Rifaximin Decreases Post-TIPS Hepatic Encephalopathy Philip Schoenfeld, MD, MSEd, MScEpi, FACG Chief Emeritus-Gastroenterology Section, John D. Dingell VA Medical…
EBGI Podcasts Now Available for Streaming!
EBGI podcasts are now available on Spotify, iTunes, and Stitcher–coming soon to Google Podcasts. Be sure to subscribe so you…
Treating Helicobacter pylori Infection with Vonoprazan
Treating Helicobacter pylori Infection With Vonoprazan, A Potassium-Competitive Acid Blocker: A New Paradigm Philip Schoenfeld, MD, MSEd, MScEpi, FACG Chief…
Peroral endoscopic myotomy (POEM) for Achalasia: At Least As Good As Laparoscopic Heller’s Myotomy
In Case You Missed It Peroral endoscopic myotomy (POEM) for Achalasia: At Least As Good As Laparoscopic Heller’s Myotomy Jennifer…
Does Choice of Anticoagulant Influence Risk of Gastrointestinal Bleeding?
Does Choice of Anticoagulant Influence Risk of Gastrointestinal Bleeding? Ravy K. Vajravelu, MD, MSCE Assistant Professor of Medicine, Division of …
Adenoma Detection Rate in 45-49 Year Olds is Lower Compared to 50-54 Year Olds, but Still Higher than 25% Benchmark
Adenoma Detection Rate in 45-49 Year-Olds Is Lower Compared to 50-54 Year-Olds, But Still Higher Than 25% Benchmark Philip Okafor,…
SER-109, an Oral Microbiome Therapy, Decreases Recurrent Clostridiodes difficile Infection
SER-109, an Oral Microbiome Therapy, Decreases Recurrent Clostridiodes difficile Infection Jessica R. Allegretti, MD, MPH Associate Director, Crohn’s and Colitis…
When Is Routine Prophylactic Clipping Indicated Post-Polypectomy?
When Is Routine Prophylactic Clipping Indicated Post-Polypectomy? Jeffrey Lee, MD, MPH Research Scientist and Attending Gastroenterologist, Department of Gastroenterology, Kaiser…
When to Use Prophylactic Antibiotics for Management of Acute-on-Chronic Liver Failure?
When to Use Prophylactic Antibiotics for Management of Acute-on-Chronic Liver Failure? Sonali Paul, MD, MS Assistant Professor of Medicine, Division…
Tenapanor (IBSRELA) for Treatment of IBS-C: Effective over 26 Weeks
Tenapanor (IBSRELA) for Treatment of IBS-C: Effective Over 26 Weeks Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus)-Gastroenterology Section, John…
